A divided Georgia Court of Appeals has rejected a defense attempt to restrict the sort of expert testimony that’s acceptable in malpractice cases involving a common screening test for cervical cancer.
At issue was what a plaintiff must show in a case alleging that a lab technician missed signs of cancer in reviewing cells on a Papanicolaou (“Pap”) smear test slide. The March 28 ruling by a court divided 5-2 rejected the idea that an approach developed by two trade groups was the only acceptable method for reviewing Pap smears after a cancer diagnosis creates the prospect of litigation.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
